Michael F. Tweedle
Materials Science · The Ohio State University
Publications
179
Citations
7,240
Est. group size
—
Recurring co-author estimate
Active years
50
Publishing since 1976
Michael F. Tweedle's research focuses on contrast agents used in medical imaging, particularly MRI, including their chemistry, safety, and behavior in the body. His work spans the development of new cancer-targeted contrast agents, studies of gadolinium retention and toxicity in tissues, and evaluation of imaging technologies for detecting and guiding treatment of cancers such as prostate cancer.
Publication output has fluctuated over the last decade, with a notable dip around 2020-2022 followed by a rebound in 2023, and overall averaging about 2-3 papers per year in the most recent five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- MR Molecular Imaging of Extradomain-B Fibronectin for Assessing Progression and Therapy Resistance of Prostate Cancer
Chemical & Biomedical Imaging · 2024
- Abstract No. 323 Hitting the Bull’s Eye: A Nanoscale PSMA-Targeted Ultrasound Contrast Agent (UCA) for Prostate Cancer Molecular Imaging
Journal of Vascular and Interventional Radiology · 2024
- Pharmacokinetics and Tolerability of the Cancer-Targeting MRI Contrast Agent MT218 in Healthy Males
Investigative Radiology · 2023
- Detailed overview 510(k) cleared imaging devices from Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection
2023
- Detailed overview 510(k) cleared imaging devices from Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection
2023
- Data from Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection
2023
- Data from Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection
2023
- New Insights into the Pharmacology and Biodistribution of Gadolinium-based Contrast Agents
Radiology · 2023
- Evaluation of Physicochemical Properties, Pharmacokinetics, Biodistribution, Toxicity, and Contrast-Enhanced Cancer MRI of a Cancer-Targeting Contrast Agent, MT218
Investigative Radiology · 2022
- Gadolinium Retention in Human Brain, Bone, and Skin
Radiology · 2021
- Alternatives to Gadolinium-Based Contrast Agents
Investigative Radiology · 2020
- Next-Generation MRI Contrast Agents: Still Including Gadolinium
Radiology · 2019
- Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates
Radiology · 2018
- Science to Practice: Will Gadolinium Chelates Be Replaced by Iron Chelates in MR Imaging?
Radiology · 2018
- Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection
Cancer Research · 2017
- Radiology×5
- The Prostate×5
- Investigative Radiology×4
- Molecular Imaging and Biology×2
- Molecules×2
- Krishan Kumar
Materials Science · The Ohio State University
- Zhefeng Li
Materials Science · The Ohio State University
- Roxanna Martinez
Materials Science · The Ohio State University
- Sandip Vibhute
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Michael V. Knopp
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile